In vivo CAR-T is moving from concept to clinic and it’s redistributing analytical instrument demand in ways OEMs can’t afford to miss. SDi maps where the opportunity is shifting.

The push toward real‑time verification and pre‑analytical quality control was visible across SLAS 2026, reflected in new on‑deck sensing modules and instrumentation designed to validate runs as they occur in real-time. The full extent of new products and themes was…

The 3D cell culture market has been on a strong and sustained growth trajectory, driven primarily by the pharmaceutical and biotechnology industries. Now, a regulatory shift is poised to further amplify that momentum. The FDA…

The US Administration’s imposition of sweeping new tariffs on April 2nd of last year – ‘Liberation Day’ – (and on some subsequent occasions) was the source of great agita within boardrooms and government houses. Many countries…

As tariffs, regulatory changes, and funding shifts reshape the global landscape, SDi analysts share timely insights into how these forces are influencing the life science and analytical instrumentation market in 2025